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Summary.-The in vitro cytotoxic immune response of spleen lymphocytes from
primiparous and tumour-related mice to embryonic cells from embryos of varying
age and tumour cells has been investigated. The results indicate that lymphocytes
from both primiparous and tumour-related (i.e., tumour-bearing or tumour-excised)
animals give a response which is greater than that from cells from control mice
("virgin cells"). Moreover, in this putative anamnestic response the immune cells
detect antigenic differences in the cell populations of embryos of varying age, which
are not as readily demonstrable when cytotoxicity is derived from virgin cells. As
a further indication of the in vivo priming to embryo-associated antigens, the data
show that the precursors ofcytotoxic cells apparently undergo a blastogenic response
in the presence of embryo antigen, and revert to small quiescent cells when antigen
is removed, in a way entirely analogous to that described for reactivity of mixed
leucocyte cultures to antigens of the major histocompatibility complex. Finally, it
seems that in animals immediately after removal of embryonic antigen (and to a
lesser degree in virgin or late-embryo-immune mice) there exists a suppressor cell
population which inhibits an anti-embryo cytotoxic response far more than an anti-
allograft response.
THE immune response of adult mice
challenged with histoincompatible cells
results in the generation ofantigen-specific
cytotoxic T lymphocytes (CTL) able to
recognize the H-2K/D specificities ex-
pressed by the antigen stimulating cells
(Alter et al., 1973). Furthermore, such
alloantigen-primed CTL have been shown
to confer, in a similar antigen-specific
fashion, protection against allogeneic
tumour-cell growth in vivo (Cohen, Glo-
berson and Feldman, 1971).
In contrast to these findings, adult
cells stimulated with embryonic antigens
(expressed on naturally occurring or
chemically/virally induced tumours) have
not been reported to show specificity
towards embryonic antigens, even on
tumours ofa given histological type (Bald-
win, Glaves and Vose, 1972). Indeed cross-
reactivity has been reported for embryo
antigens from animals which differed at
the major histocompatibility complex
(Gorczynski, 1976a). A number of groups
have reported that immunization with
foetal tissue is ineffective as a means ofin-
ducing tumour-immunity (Pearson and
Freeman, 1968; Ting, 1968; Basombrio
and Prehn, 1972). In contrast to this,
several workers, using SV40-induced tu-
mours (Coggin, Ambrose and Anderson,
1970) and Rauscher-leukaemia-virus-in-
duced tumours (Hanna, Tennant and
Coggin, 1971) have suggested that foetal
immunization can confer tumour immu-
nity. Perhapsevenmore strikingare theex-
ampleswhere foetalimmunization hasbeen
shown to enhance the growth of tumours
expressing embryo-associated antigens
(Castro et al., 1973; Parmiani and Lembo,
1974). In addition, a recent communica-
tion from this laboratory showed that
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while lymphocytes from normal healthy
adults spontaneously developed cytotoxi-
city directed against embryonic antigen
determinants in tissue culture, the reactive
cells were not universally CTL (Gorezyn-
ski, 1976b). In particular, in female
lymphocytes, the reactivity seemed to be
associated with a B lymphocyte/macro-
phage cytotoxic response.
In anefforttoexamine in a more system-
atic fashion the potential reasons for the
differences cited above, the ability of
lymphocytes takenfrom animals atvarious
stages of pregnancy or tumour growth to
show reactivity to embryo fibroblasts from
embryos of varying ages has been exam-
ined. The data described below indicate
that lymphocytes from animals pre-
exposed to embryonic antigens show a fine
specificity not shown by virgin cells in
terms of in vitro induction of secondary
cytotoxicity. Moreover, evidence is pre-
sented to show that during tumour (or
embryo) growth and at early times after
tumour (or embryo) excision a cell popu-
lation exists which is capable of inhibiting
the immune response to embryonic anti-
gens (and, considerably less effectively, to
histocompatible cells).
MATERIALS AND METHODS
Mice.-C3H/HeJ and (C3HxC57BL/6J)Fj
mice were obtained from the Jackson Lab-
oratories, Bar Harbour, Maine. All animals
were kept 5 to a cage and given food and
water ad libitum.
Termed pregnancies were induced by put-
ting male and female mice together for
16-20 h. Pregnant mice (vaginal-plug tech-
nique) were separated from the remaining
mice. Birth occurred at 19 to 20 days of
gestation.
Tumours.-Retired breeder mice from
Jackson Laboratories were inspected twice
weekly for the appearance of spontaneous
tumours. When such a tumour was ,1 cm3
in volume, the animals were killed by cervical
dislocation and the tumour removed aseptic-
ally in phosphate-buffered saline (PBS). A
sample ofthe tumour was taken to the Histo-
logy/Pathology Department for analysis.
Unless otherwise specified, all tumours used
throughout these experiments were adeno-
carcinomas of female mice. Neoplasms were
disaggregated with a mixture of trypsin
(2.5% solution, Grand Island Biological
Company, Grand Island, New York), crude
collagenase (CLS 11, 140 u/mg; Worthington
Biochemical Corporation, Freehold, New
Jersey) and deoxyribonuclease (DNase 1,
B Grade, 7 x 104 Dornase units/mg; Calbio-
chem, San Diego, California) as described
by Russell et al. (1976). All enzymes were used
at a concentration of 0.1 mg/ml and the
tumour cells were harvested from the diges-
tion flask at 30 min intervals for a total of
90 min. The mean yield per tumour was
1-4 x 107 cells.
2-5 x 105 tumour cells were transferred s.c.
into the back (in 0-2 ml PBS) to each of 15
8-week-old female C3H/HeJ mice, and the
growth ofthese tumours followed. In the case
of these primary recipient animals, when the
tumour was about 1 cm3 the animals were
either killed and used as a source of test
lymphocytes, or anaesthetized with Nembu-
tal and the tumour mass excised.
Fibroblasts.-Embryo fibroblast cells were
prepared from C3H embryos of varying ages
as described before (Gorczynski, 1976a).
Fibroblasts, primary tumour cells, and fresh
single cell suspensions of embryo cells (pre-
pared as for the tumour suspension above)
were stored in liquid N2 at a concentration
of 2 x106 cells/ml in cxF30 (a-MEM supple-
mented with 30% FCS) with 15% dimethyl
sulphoxide. All cell counts here and subse-
quently refer to viable cells as determined by
trypan-blue-dye exclusion.
Cell preparation, irradiation, 51Cr-cyto-
toxicity assays and velocity sedimentation.-
These have been described in detail in pre-
vious publications (Gorczynski, 1976a, c;
Miller and Phillips, 1969).
Microcytotoxicity assay.-The assay was a
modification of that previously described
(Gorczynski, 1976a). Target cells for the
microcytotoxicity assay were 3H-proline
labelled (630 mCi/mmol, Radiochemicals
Centre, Amersham, England) embryonic
fibroblasts. 3H-proline was used, rather than
3H-thymidine as previously, in view of the
superior uptake of label, lower rate of
spontaneous release, and decreased re-utili-
zation of the label by lymphocytes or
unlabelled embryonic fibroblasts in proline
containing aFlo (Bean, Rosen and Oettgen,
1973).
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After labelling the embryonic fibroblasts
with 150 1zCi of 3H-proline for 18 h in 3 ml of
proline-free acF5 the fibroblasts wrere washed
twice in PBS, trypsinized and washed twice in
oxF1o. The cells were then resuspended to a
concentration of 104/ml and 100 1J of cells
dispersed into each well of a 96-well (6 mm)
Limbro microtest plate (Liinbro Chemical
Company, New Haven, Connecticut). After
allowing 3 h for the fibroblasts to adhere to
the bottom of the wells, effector cells were
added in 100 pul to each well. Various con-
centrations of effector cells (always in 100 [I)
were used, and control groups contained
either oF1o alone (medium control) or deter-
gent (total releaseable ct/min). All groups
were set up in triplicate.
After 24 h the plates were centrifuged
(500 g for 5 min at 4°C) and 100 ,ul of the
supernatant in each wN-ell harvested, dis-
solved in 5 ml Aquasol (New England Nuclear,
Boston, Mass.) and counted in a scintillation
counter. Percent specific cytotoxicity was
calculated as:
(t/min experimental -
100 x (ct/min spontaneous ct/min detergent -
ct/min spontaneous/
Where possible, all data are expressed as
arithmetic mean5s.e. mean. W;ithin any
given experiment described herein, the target
cells were from the same frozen stock.
Cell cultures. All cells sensitized against
allogeneic or syngeneic cells were cultured in
16 mm Limbro culture plates, in a total
volume of 2-5 ml ocFlo per well. The plates
were initially pre-cultured for 4 h at 37°C in
an humidified C02-containing atmosphere
with 2-0 x 105 normal peritoneal macro-
phages per well (in 0 5 ml aF1o). Then 5 x 104
freshly prepared embryo cells (not embryo
fibroblasts) or tumour cells were added to
each well in 200 ,ul ocFo and the plates were
returned to the incubator for a further 2 h.
The individual wells were then washed
twice, each time with 2 0 ml of pre-warmed
ocFlo, the plates irradiated with 2500 rad in a
137Cs irradiator, and lymphocytes added to
the wells described. The plates Awere now
returned to the incubator for 5 days, after
which the cells in the wells were harvested,
washed twAice in ouF1o and assayed as
described.
RESULTS
Cytotoxicity offreshly prepared lymphocyte
populations to embryonic fibroblasts made
from embryos of varying ages.
Earlier reports from this and other
laboratories (Gorczynski, 1976a; Baldwin
et al., 1974; Hellstrom and Hellstrom,
1976) have shown that lymphocytes from
tumour-bearing (and tumour-excised) mice
and primiparous mice are naturally cyto-
toxic for embryonic fibroblasts prepared
from mid-gestation embryos. In addition,
it has proved possible to sensitize allegedly
virgin cells to embryo-associated antigens
under tissue-culture conditions, though no
extensive analysis of such sensitization
has been performed with cells already
primed in vivo. In order to investigate
whether in vrio priming during pregnancy
or tumour growth takes place to unique
antigens associatedwith cellsfrom embryos
of varying ages, we have therefore com-
pared the cytotoxicity of such sensitized
lymphocytes during the ongoing primary
and secondary response.
The data of Table I (the pooled results
from 5 independent experiments) show
the cytotoxicity of spleen lymphocytes,
prepared from animals at different stages
of in vrio sensitization to embryonic
antigen, to embryo fibroblasts prepared
from different ages of embryo. As already
reported, freshly prepared virgin lympho-
cytes showed negligible cytoxicity to the
fibroblasttargets, andthe same wastruefor
lymphocytes prepared from animals at
long times after tumour resection. In
contrast, during pregnancy or tumour
growth, cytotoxicity to embryonic fibro-
blasts was apparent, with a degree of
specificity attached to the cytotoxicity.
Thus lymphocytes early in pregnancy
showed optimum cytotoxicity to fibro-
blasts from young embryos, and only later
did cytotoxicity to fibroblasts from older
embryos appear.
Specificity of re-stimulation of embryo-
primed cells in tissue culture
The data in Table I are consistent with
the notion that different embryonic anti-
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TABLE I.-Cytotoxicity ofFresh Spleen-Cell Preparationsfor Fibroblasts
from Embryos of Different Ages
Source of
spleen cellst
Normal adult
Pregnant (8 days)
Pregnant (11 days)
Pregnant (14 days)
Pregnant (18 days)
20 days post-partum
Tumour bearer
10 days after tumour
resection (tumour-free)
30 day tumour
resection (tumour-free)
Specific cytotoxicity: to
I A
Cef8
1-0±0-2
1 -2±0- 3
4.1±1.9*
2- 7±0- 4*
6.8±3.1*
2.4±0.9*
3 4±0 9*
4.8±1.6*
2-2±1-1
Cefil
0-8±0i 1
1-0±0- 2
4 7±2- 1*
8.9±2.8*
8. 6±2 4*
2-1±0- 6
4 7±115*
6- 1±2 .9*
1 -9±0- 4
Cef14
1-1±0- 3
0-9±0-4
4.2±2.1*
8-7± 3-6
10*
4 1±0.9*
4 8±2-2*
47±1- 6*
2-5±1-1
Cef18
1-1±0-3
1-1±0-3
0-9±0- 2
1 -6±0-4
3.2±1.1*
1 -1±0- 4
1- 1±0- 3
1 -6±0- 9
1- 1±0- 4
*P<0.05.
t Spleen cells were harvested from individual mice of the type shown. Tumour cells were prepared from
spontaneous adenocarcinomas and passaged into 20 recipients. The primary tumour transplant was removed
when 1 cm3, the spleens of these animals being used at the times after surgery as shown. In all cases
cells were lysed with Tris-buffered ammonium chloride and the lymphocyte pool was washed and resuspended
in xF10. Various numbers of lymphocytes were then added to 103 3H-proline-labelled embryo fibroblast
target cells.
t Arithmetic mean (±s.e.) of cytotoxicity at 24 h to 3H-proline-labelled embryo fibroblasts, using a 50: 1
effector:target ratio. The data are arbitrarily normalized to 10% specific lysis of Cefl4 by lymphocytes from
an 18-day pregnant animal. The data are averaged over independent experiments (all performed with the
same batch of frozen target cells), the standard errors thus representing the variation between experiments.
gens are expressed at unique times during
embryonic growth, and that subsets of
cytotoxic cells develop with reactivity to
these antigens. In order to examine in
greater detail such specific reactivity to
unique embryonic antigens, spleen cells
were harvested from animals at different
times during pregnancy or tumour growth
and triplicate cultures of 5 x 106 cells were
challenged in tissue culture for 5 days
with embryonic cells of different ages or
semi-allogeneic (C3H xC57BL/6)F1 spleen
cells. Each antigen was presented in a
form bound to macrophage monolayers
(see Materials and Methods). Following
this the spleen cells from individual
groups were pooled and harvested, washed
in cxFlo, and tested at various effector:tar-
get ratios for their cytotoxicity to 3H-
proline-labelled fibroblasts (prepared from
embryos of different ages) or to 51Cr-
labelled EL4 tumour cells. Results of a
typical experiment (1 of 4) are shown in
Fig. 1.
There are several features of interest in
this figure. The data in the 3rd column
indicate that all spleen cells responded
qualitatively and quantitatively to the
same degree to an allogeneic stimulus (as
assayed by EL4 tumour targets). However,
for all lymphocytes putatively immunized
to embryonic antigens, a source ofstimula-
tor/target cells existed which revealed a
quantitatively greater response from these
lymphocytes than from normal cells. The
degree ofsignificance to be attached to the
differences documented in this and subse-
quent Figures is readily appreciated, given
that within each experiment the data
points have an s.e..8% of the arithmetic
mean. Furthermore, the data display once
more the specificity suggested in Table I.
Thus only cells from late-pregnant animals
(primiparous 14/18) and not from virgin
or early-pregnant mice were readily stimu-
lated to show cytotoxicity with C18 cells
(from 18 day foetuses) (x .... X ). Con-
versely, cells from early-pregnant miice
(primiparouslo) were optimally stimulated
by C1o, though, in contrast to the findings
after stimulation with C18 (above), primi-
parous18 cells were also stimulated to cyto-
toxicity byC1o. One interpretation ofthese
data is that subsets of cytotoxic cells
develop with preferential cytotoxicity to
antigens which are acquired (and lost) at
789R. M. GORCZYNSKI
Cef10
0) Virgin
30 30
... -~
b) Primiparousio
60 ,
30
0
c) Primiparousl4
60 -_ C o
0
30
d)PrImlpOrous18
30
e) Adenoa
,60 _ _o
f)Adeno, resected 20da
90
60 [I
o x g) Adena2
60
30 -0--a
0 .*....
X
90 Adeno2- c
60 0-~*~~~~°
60
a- .00
30
20:1 100:1 200:1 2C
Effectc
Cef14 Cef18/EL4
.X *---.'6
lys
-.
0~~~~~~~-
Jays L
t.. i.-_o --
D:I 100:1 200:1 20:1 100:1 200:1
or: target ratio
FIG. 1. 24 h cytotoxicity of spleen cells from
various sources to fibroblasts from embryos
of different ages after stimulation of the
spleen cells in culture with cells from
different age embryo cells. Rows (a) to (h)
represent the source of spleen cells. Adeno1
and adeno2 represent spleen cells from mice
bearing different adenocarcinomas, and
adenoL resected 10 (lays, adeno2 resected 20
(lays, the cells recovered from such mice 20
days after surgical removal of the tumour.
All points represent arithmetic means of 3
readings at the effector: target ratio shown.
103 3H-proline labelled targets and a 24 h
test assay were used in all cases except for
cytotoxicity to EL4 tumour target cells,
wNhich was measured in a 4 h 51Cr-release
assay using 5 x 104 al CR-labelled target
cells. Data in the columns shown represent
the cytotoxicity to the different tar-
gets after stimulation with 10 (O- - ),
14 (--*) or 18 (x *... x ) day embryo
cells respectively. The broken linie in the
third column shows the cytotoxicity to EL4
tumour targets after stimulation with
(C3H x C57BL/6)Fl spleen cells (in this
the effector: target ratios shown are
2: 1, 10:1 and 20: 1).
unique times in embryo development.
Thus primiparous1o lymphocytes react like
virgin cells to antigens on C18 (or Cefis,
fibroblasts from 18-day foetuses) while
primiparous18 lymphocytes contain "mem-
ory" cells for Clo, C14 and C18.
No less interesting were the data seen
with cells from tumour-bearing or tumour-
excised animals (last 4 rows of Fig. 1). It
was clear that the cytotoxic response
from tumour-excised mice was greater
than from tumour-bearer. Moreover, cells
from the individual tumour groups show
signs of the same specificity phenomenon
as cells from animals at different times
after pregnancy. Thus adeno, cells were
optimally stimulated by Clo and now
showed significantly (P<0.05) greater
cytotoxicity to Ceflo than Cefi4. That this
is not simply caused by a quantitative
difference in expression of one antigen
between C1o (Cef1o) and C14 (Cefi4) cells is
indicated by the reverse situation in
which adeno2 cells were stimulated signi-
ficantly more by C14 than by C1o, even
though almost equivalent cytotoxicity was
seen on Cef1o with such stimulated cells.
One interpretation ofthe data is that there
is a difference in antigen expression of at
least 2 antigens, one preferentially expres-
sed on C1o (Cef1o) and one on C14 (Cef14)
each of which can induce subsets of cyto-
toxic cells preferentially reactive with the
different antigens.
Inhibition of cytotoxicity indutced in anti-
embryo-immunized cells in culture by target
cells bearing the appropriate embryo antigens
The cross-reactive cytotoxicity genera-
ted in the in vitro-stimulated cultures
above (e.g., in which C14 ( 0)
stimulated cells were often highly cyto-
toxic to Ceflo targets) might be explained
by the presence of cross-reactive antigens
on the stimulator/target cells and/or
cross-reactive populations of cytotoxic
cells. We have investigated this problem
by performing "cold competition" experi-
ments in which lymphocytes were sensi-
tized in vitro with Clo, C14 or C18 and then
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assayed on 3H-proline-labelled Cef14 in
the presence of excess cold C1o, C14 or C18.
In a "criss-cross" specificity test, cells
from the 14-day pregnant animal were also
assayed against 3H-proline labelled Ceflo
targets. The data for one experiment (of 3)
are shown in Fig. 2. It should be noted
that as control experiments we have tested
on several occasions the inhibition of
cytotoxicity to Cef with unrelated "cold"
EL4 tumour target cells, and at no time
has any significant perturbation of cyto-
toxicity been seen. Irrespective of the
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FIG. 2.-Cold competition experiments with
cells sensitized against cells from embryos
of different ages and assayed against 3H-
proline-labelled Cefs4 (Row (e) alone was
assayed against Cefio). All points represent
the arithmetic mean of 3 cultures, assayed
at a 100: 1 effector: target ratio. The vari-
ous spleen cells shown in Rows (a) to (e)
were sensitized against the various ages of
target embryonic cells (shown as C1o, C14
and C18), and tested in a 24 h microcytotoxi-
city assay in the presence of additional
"cold" C10 (0-- 0), C14 (0 *) or
C18 (x x) cells, added immediately
before the cytotoxic cells.
source ofstimulator cells orresponder cells,
cytotoxicity to Cef14 in all cases was opti-
mally inhibited by C14 cells (Panels a to d).
This was despite the quantitative differ-
ences in cytotoxicity seen when different
lymphocyte sources were used asresponder
cells (Panels a to d) or when the sourceof
stimulator cells was varied (rows, Fig. 2).
These quantitative differences were similar
to those in Fig. 1. When cytotoxicity was
measured using Ceflo as target, however,
the optimum inhibition was seen with Clo,
again irrespective ofthe source ofstimula-
tor cells (Panel e). Taken together, these
data argue strongly that the cells causing
cytotoxicity represent unique subsets of
cells responding to different antigens,
which were expressed in different patterns
on the various stimulator/target cells used.
Thus the cells of primiparousl4 (P14) cyto-
toxic to Cefi4 after stimulation by 0lo
(Panel b) were not the same cells assayed
when reactivity to Ceflo was studied
(Panel e). Thus the cross-reactivity seen
inFig. 1 was mostlikely duetothevariable
ability of a given stimulator or target to
induce or be "killed" by different subsets
of cytotoxic cells.
Comparison of the data obtained with
adeno3 and adeno5 with the data in the
upper two rows (with virgin cells and
primiparous14 cells respectively) of Fig. 2
and those of Fig. 1 suggest that adeno3
cells were preferentially reactive with an
early-appearing embryonic antigen and
adeno5 with a later appearing embryo anti-
gen. Cold competition experiments of the
type above with cells from tumour-bearing
animals gave similar results (unpublished
data) supporting the concept ofindividual
subsets of cytotoxic cells.
Evidenceforincreasedreactivitytoembryonic
antigens after stimulation with tumour cells
In an auxiliary test of the similarity of
the findings in tumour-related and preg-
nant mice, we have examined the speci-
ficityofcytotoxicity to fibroblasttargets of
lymphocytes from tumour-resected ani-
mals re-stimulated in culture with either
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FIG. 3.-Specificity ofre-stimulation ofspleen
lymphocytes from tumour-resected mice
with cells from embryos of different ages
(CIO (O- - 0), C14 (0 0) or C18
( x x ) or tumour cells themselves
(adeno8(E -*-* OD) or adeno 12 (A- - * A))-
The data are described in more detail in
the text and previous figure legends. Row
(a) refers to re-stimulation of adeno8
tumour-resected spleen lymphocytes, Row
(b) to adeno12 spleen cells. All data repre-
sent the arithmetic means of 3 cultures per
point. Data in the 3 columns indicate the
cytotoxicity to 3 targets, Cef1o, Cef14 and
Cef18 respectively.
tumour cells (adeno8 and adeno12, see
Fig. 3) or embryonic cells respectively. The
data for this experiment are shown in
Fig. 3. Similar data have been obtained
with other tumours.
Comparison of these data with those of
Figs. 1 and 2 led to several interesting
conclusions. The quantitative optimum
cytotoxicity seen with adeno8 tumour-
resected spleen cells was directed against
Cef14, and was seen after stimulation with
C14 (0 ) and adenos (C]
cells. Highly significant reactivity with
Cef18 (or Cefio) was only seen after stimu-
lation with autologous tumour cells or
late or early embryo cells. These data
suggest that adeno8 lymphocytes were pre-
ferentially responsive to late-appearing
embryonic antigens. By contrast, adeno12
cells were optimally stimulated with Clo
(0 O) or adeno12 (A- A) cells,
gave their optimum reactivity with Ceflo,
and were poorly reactive with Cef18, even
after stimulation with C18. Such data were
best explained in terms of a preferential
response ofadenol2 cells to early-appearing
embryonic antigens.
Sedimentation analysis of precursors of
cytotoxic cells at different times after
exposure to embryonic antigens
A number of workers in recent years
have investigated the homologous secon-
dary response in mixed leucocyte cultures
in cells challenged previously in vitro or in
vivo with histoincompatible cells (Hayry
and Anderson, 1975; Hollander, Ginsburg
and Feldman, 1974; MacDonald, Cerottini
and Brunner, 1974). The data collected
from such studies have led to the concept
of alternate cycles of blastogenesis (and
development of cytotoxic potential) fol-
lowed by quiescence (and a return to
inactive small cells). We have investigated
this phenomenon in cell populations which
are presumably responding to embryonic
antigens. Before re-stimulation ofthe cells
in culture the responding spleen lympho-
cytes were fractionated by Ig sedimenta-
tiontoinvestigatethesizeofthe precursors
of cytotoxic cells.
Spleen cells were pooled from a mini-
mum of 2 mice, and 2 x 108 cells were
sedimented at 4°Cfor 4 hinaBSAgradient
ranging from 0.3% to 2-0% in PBS. After
this time fractions corresponding to cells
with differences in sedimentation velocity
of 10 m/h were collected and the viable
cells/fraction counted. No reproducible
significant difference in nucleated-cell
sedimentation profile in the various
groups was noted. The cells were washed,
resuspended in oaFlo and the primiparous
or tumour-related cells were stimulated in
culture for 5 days with C14 or adeno17
cells respectively. The spleen cells from
the various groups were then harvested,
resuspended in oaFlo to volumes equivalent
to their recovery in the original fractiona-
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FIG. 4.- Sedimentation analysis of cells re-
sponding after secondary stimulation in
vitro with embryo-associated antigens to
give cells cytotoxic to Cef14 in a 24 h
microcytotoxicity test. All points represent
the arithmetic mean of 3 cultures. The
data are described in more detail in the
text. All cells in the first column were
derived from primiparous C3H animals at
various stages of pregnancy, and were sti-
mulated with C14 embryo cells. Spleen
cells in the second column were derived
from mice receiving adenocarcinoma17
tumour cells and were re-stimulated with
adeno17 cells in vitro before assay with
Cefs4 target cells.
tion procedure on Day 0, and tested at
different effector: target cell ratios for
their cytotoxicity to Cef14. This was
known to represent the optimum target
for C14-stimulated primiparous cells and a
suitable target for adeno17 lymphocytes
(see Figs. 1-3). The data in Fig. 4 represent
results from one of 3 experiments of this
type. Similar data were obtained with
other tumour-bearing or tumour-resected
animals (though the cytotoxicity measured
varied in degree, e.g., Fig. 3). All points
indicate the cytotoxicity measured from
volumes of fractionated cells representing
a 100: 1 effector: target ratio in the un-
fractionated cell population.
It is quite apparent from the data ofthis
Figure that changes in the physical size
of the precursors of cytotoxic cells for
anti-embryo responses did indeed occur,
in a manner analogous to anti-allograft
responses. The precursor cells in virgin
animals have been found to reside in a
pool of slow-sedimenting small lympho-
cytes (2-4.5 m/h-unpublished data). In
contrast to this, the precursor cells in
pregnant mice (re-stimulated with C14) or
tumour-bearing mice (re-stimulated with
autologous tumour cells) sedimented with
peak velocity 7-10 mm/h (Panel a, Fig. 4).
Immediately after birth or tumour resec-
tion, there was evidence for 2 populations
of precursor cells (Panel b) while at much
later times the size of the precursor cells
resembled that in virgin animals. As yet,
no formal proof is available that the small
cell (in virgins) gives rise to the memory
large cell (tumour-bearing or P14) which
later reverts to a small cell after antigen
removal. Nevertheless, the ability to
inhibit the development of cytotoxicity in
re-stimulated cultures by treatment before
culture with anti-Br6* (Gorczynski, in
preparation) and the similarity ofmuch of
these data with earlier studies on allo-
antigen-primed cells (HayryandAnderson,
1975) suggest they are indicative of the
same phenomenon.
Evidence for specific inhibition of anti-
embryo (not anti-allograft) responses in mice
at early times during pregnancy/parturition
and tumour growth
The data above show that the secondary
response of tumour-resected lymphocytes
to embryo-associated antigens was in-
creased dramatically relative to the re-
sponse of tumour-bearer cells, and also
that the precursors of the cytotoxic cells
changed size after tumour removal. The
lack of continuity in this size change of
precursor cells (see the biphasic distribu-
tion of Panel b, Fig. 4) suggested that the
enhanced response of tumour-resected
cells may in part be due to loss of an in-
* Rabbit antiserum to mouse brain, associated
with 0 antigen.
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TABLE II.-Specific Inhibition ofAnti-embryo Responses by CellsPreparedfrom Tumour-
bearing or Early Tumour-resected Animals, or Animals during or after Pregnancy
% Specific cytotoxicityt to
I I
Cef,4t EL4§
Source of added ,A.________
spleen-cells* 2 x 105 lOx 105 2 x 105 lOx 105
Virgin female 45±3-9 27±2 - 9 39±2 -1 30±1-9
Pregnant (14 days) 22±3 -1 9±1*9 37±1- 7 26±2 -2
2days post-partum 25±3-4 16±2-4 35±1-5 25±1-7
30 days post-partum 40±4- 6 24±2 -9 42±2 -2 32+1- 8
Tumour bearer 16±2-4 6±1-9 37±1-7 28±2-1
10 days after tumour
excision 25±3-6 12±3-2 36±1-9 30±1-8
30 days after tumour
excision 46±5-8 32±4-6 37±2-2 31+2-0
* Spleen cells with sedimentation velocity 4-5-7 0 mm/h were prepared from the sources shown as
described in the text. These cells were added to the sensitizing cell mixture before 5 days of culture.
t % specific cytotoxicity derived from spleen lymphocytes (pooled from 4 animals at 25-35 days post-
partum) sensitized (along with 2 x 105 or 10 x 105 of the cells in the first column) against C14 embryo cells
or (C3H x C57BL/6J) F1 spleen cells.
t Cytotoxicity to Cef14 was measured with a 24h 3H-prolinemicrocytotoxicity assay. Allvolumes represent
the arithmetic mean (±s.e.) of 3 assay cultures, at a ratio representing an 80:1 (effector:target) ratio for
the control group containing no added sedimented cells. For this control group the cytotoxicity to Cefp4 was
42±4-1.
§ Cytotoxicity to EL4 tumour cells was measured by a 4 h 51Cr-release assay. The effector:target ratio
in this case was represented by a 20:1 ratio for the control culture, which in turn gave 39±1 -9% specific
cytotoxicity.
hibitory population. Accordingly, we have
investigated the ability of cells with sedi-
mentation velocity 4-5-7-0 mm/h (Panel
b-Fig. 4) to inhibit anti-embryo or anti-
allograft cytotoxic responses.
Spleen cellswerepooledfrom aminimum
of 3 animals per group at various times
after pregnancy induction or tumour
growth, and 2-0x 108 of each of the pools
was sedimented for 3 h at 4°C. From each
source the population of cells sedimenting
with velocity 4-5-7-0 mm/h was collected,
and varying numbers of these cells were
mixed with 5 x 106 spleen lymphocytes
from apoolof4animals at 25-35dayspost-
partum. The cell mixtures were then
sensitized for 5 days in culture with C14
embryonic cells or with (C3H xC57BL/6J)
F1 spleen cells. All culture groups were set
up in triplicate. After 5 days, the cells
within a given group were pooled, and
assayed at a constant ratio with 103 3H-
proline-labelled Cefl4 or with 5 x 104 51Cr-
labelled tumour target cells (EL4). The
ratio used was that representing an effec-
tor:target ratio of 80: 1 (vs Cefi4) or 20: 1
(vs EL4) in the control group receiving
only the primiparous cells. The data for
one experiment of 2 ofthis type are shown
in Table II.
These data support the conclusions
drawn from Fig. 4. The sedimented cell
population of all spleen cell sources used
gave negligible inhibition of the allo-
geneic cytotoxic response with 2 x 105
cells per 5 x 106 responder cells, and caused
a mean inhibition of some 30% of the
control response with 10 x 105 cells-all
spleen-cell sources gave about the same
inhibition. In contrast, even 2x105 cells
derived from the spleens of pregnant or
tumour-bearing animals, or of animals
soon after removal ofthe source ofembryo
antigen, caused highly significant (>50%
with tumour-bearer cells) inhibition of
cytotoxicity against Cef14. With 106 cells,
even virgin-female cells caused appreciable
inhibition ofthe anti-embryo response (see
also Gorczynski, 1976d) but again the
maximum inhibition (now 80% to 90%)
was seen with cells from pregnant or
tumour-bearing animals. At longer times
after birth or tumour excision (30 days)
this particular sedimented spleen-cell pop-
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ulation was no more able to inhibit an
anti-embryo response than a similar
population prepared from virgin female
cells.
DISCUSSION
In earlier studies (Gorezynski, 1976a, d)
we reported that virgin mouse lympho-
cytes spontaneously developed a cytotoxic
response in vitro to embryo-associated
antigens, that male cells apparently re-
sponded in a different fashion from female
cells, and that female non-T cells could
suppress the development of an anti-
embryo response. Given the evidence for
some sex-associated differences in the
natural frequency of occurrence of a
variety of tumours in humans (Silberberg
and Grant, 1970), it was thus tempting to
speculate that an autoreactive (anti-
embryo) response in animals might indeed
modulate tumour growth for a tumour
expressing embryonic antigens, and that
such an effect would be most marked in
animals pre-exposed to the embryonic
antigen. A necessary corollary of such a
hypothesis however is that animals which
have been exposed to embryonic antigens
(by pregnancy or growth of a tumour
expressing embryo-associated antigen)
should show an anamnestic response to
such antigens different from normal (vir-
gin) cells, perhaps analogous to that
recently described by Wekerle (1977) for
testicular autoantigen.
In gathering the data described in this
report we have attempted to throw light on
these questions. In essence it was found
(Fig. 1) that, at different times after
initiation of pregnancy or induction of
tumour growth, differential susceptibility
to re-stimulation with cells from embryos
of different ages is seen. Lymphocytes
from early-pregnant animals responded
preferentially to early-embryo cells and
vice versa. Tumour-bearer or tumour-
resected lymphocytes could also be re-
solved, in terms of their pattern of reac-
tivity to cells from different-aged embryos
(Fig. 1-3) into populations akin to those in
early-/late-pregnant animals. Cold com -
petition experiments (Fig. 2) suggested
that the most plausible explanation of the
data was that cytotoxicity was due to
individual clones of cytotoxic cells, each
with preferential reactivity to target cells
bearing age-related embryonic determi-
nants. Different tumours might then pre-
ferentially induce clones of cytotoxic cells
which were specific for the embryonic anti-
gen carried by that particular tumour.
The data of Fig. 3 show an additional
corollary of this hypothesis, in that the
pattern of reactivity of cells from tumour-
resected animals was analogous to that
seen with early-/late-pregnant animals
when the cells were re-stimulated with
autologous tumour cells or cells from
different-aged embryos.
In addition to this evidence for fine
specificity discrimination in cells from
animals previously exposed to embryonic
antigen, evidence was obtained (Fig. 4)
that the precursor cells for cytotoxic cells
underwent size transitions after embryonic
antigen challenge/removal in a manner
reminiscent of that seen with lymphocytes
from animals primed with cells differing
at the MHC (see MacDonald et al., 1974;
Hayry and Anderson, 1975; Hollander et
al., 1974). Furthermore, both tumour
bearer/pregnant animals and animals
early after removal of in vivo antigen
challenge were found to contain a popula-
tion of cells with peak sedimentation
velocity (4 5-7 0 mm/h) which could pre-
ferentially inhibit a response to embryo-
associated determinants (relative to the
response to allo-antigen determinants)-
see Table II. This population was already
demonstrable, though to a lesser degree, in
virgin females, and may be the same as
that previously reported in such animals,
and characterized as a non-T-cell popula-
tion (Grorczynski, 1976d). The relationship
of the cytotoxic cell precursors and inhibi-
tory cells in virgin and embryo-antigen-
exposed animals, and the effects such
cells produce upon adoptive transfer to a
tumour-bearing host, remain the topics of
future investigation.
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